Brief: AC Immune Presents First In Vivo Images Of Brain Tdp-43 Pathology From Phase 1 Trial Of Pet Tracer Aci-19626, At Ad/Pdtm 2026
19/03/2026 12:08
March 19 (Reuters) - AC Immune SA ACIU.O: AC IMMUNE PRESENTS FIRST IN VIVO IMAGES OF BRAIN TDP-43 PATHOLOGY FROM PHASE 1 TRIAL OF PET TRACER ACI-19626, AT AD/PDTM 2026 Source text: ID:nGNX2CR4tQ Further company coverage: ACIU.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture